AI assistant
Twist Bioscience Corp — Director's Dealing 2021
Aug 10, 2021
31873_dirs_2021-08-10_7235f6fd-7956-4c45-96a9-dd757354104d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-08-05
Reporting Person: Starovasnik Melissa A. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-05 | Common Stock | A | 1369 | — | Acquired | 1369 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-05 | Employee Stock Option (right to buy) | $124.12 | A | 2739 | Acquired | 2031-08-04 | Common Stock (2739) | Direct |
Footnotes
F1: Represents a restricted stock unit award ("RSU") of which 1/3rd of the total number of RSUs vest on each anniversary of August 5, 2021, for a total vesting period of 3 years, subject to the Reporting Person's continuous service through each vesting date.
F2: 1/3 of the shares subject to the option vest and become exercisable on the first anniversary of August 5, 2021, and 1/3rd of the shares subject to the option vest and become exercisable on each anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.